Search results
Sandoz Settles Patent Dispute With Amgen Related To Bone Disorder Drug Denosumab
Benzinga via Yahoo Finance· 2 days agoGeneric and biosimilar manufacturer Sandoz AG (OTC:SDZNY) (OTC:SDZXF) reached an agreement on...
Amgen, Sandoz Settle Clash Over Biosimilars of Blockbuster Drugs
Bloomberg Law· 3 days agoand Sandoz Group AG settled a patent-infringement lawsuit over biosimilar versions of Amgen’s Prolia and Xgeva bone-strengthening treatments, according ...
Sandoz reaches agreement with Amgen over patent dispute
KFGO· 2 days agoZURICH (Reuters) - Swiss generic and biosimilar manufacturer Sandoz said on Tuesday it had reached an agreement with U.S. drugmaker Amgen resolving all patent litigation related to its U.S. ...
District Court: Accused Infringer Bears the Burden of Timely Raising a Non-Infringing Alternatives...
JD Supra· 3 days agoIn a patent infringement case, the district court granted plaintiff’s motion to strike portions of defendant’s technical expert’s rebuttal report on the ...
Shanghai handled over 60 cases of foreign-related patent infringement disputes
China Daily· 6 days agoShanghai has handled more than 60 administrative adjudication cases of foreign-related patent ...
Apple Watch Ultra 2 long-term review: Your move, Samsung
Android Central via Yahoo News· 5 days agoThe Apple Watch Ultra 2 only has one real Android watch equivalent: the Galaxy Watch 5 Pro, which...
European Patent Court Issues Preliminary Injunction Against Curio Bioscience in Three Countries
GenomeWeb News· 23 hours agoThe European Unified Patent Court (UPC) on Tuesday issued a preliminary injunction against Curio Bioscience in a patent infringement case brought by 10x ...
The Second Time’s a Charm: In New Damages Trial, Texas Jury More than Doubles Lump-Sum Award Against...
JD Supra· 18 hours agoOn April 17, 2024, a second Texas jury assessed damages of $142 million against Samsung, more than doubling a previous jury award of $67.5 in a protracted standard essential patent (SEP) litigation ...
Federal Court finds patent for concentrated methotrexate solutions obvious | JD Supra
JD Supra· 3 days agoOn March 26, 2024, the Federal Court dismissed Medexus and Medac’s action for patent infringement of Canadian Patent No 2,659,662 (the 662 Patent), finding ...
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Benzinga via Yahoo Finance· 1 day agoWednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling...